Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paulo C J L Santos

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|March 13, 2012
Molecular diagnostic and pathogenesis of hereditary hemochromatosisPaulo C J L Santos, Jose E Krieger, Alexandre C Pereira
Pharmacogenomics|April 28, 2018
Genotype-guided warfarin therapy: current statusLetícia C Tavares, Leiliane R Marcatto, Paulo C J L Santos
World Journal of Clinical Cases|November 1, 2017
Juvenile hemochromatosis: <i>HAMP</i> mutation and severe iron overload treated with phlebotomies and deferasiroxManuel A Lescano, Letícia C Tavares, Paulo C J L Santos
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 7, 2012
Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life settingJaqueline S Issa, Tania Ogawa Abe, Simone Moura, et al.
Anais Da Academia Brasileira De Ciencias|March 12, 2015
General aspects of muscle glucose uptakeRafael O Alvim, Marcel R Cheuhen, Silmara R Machado, et al.
Pharmacogenetics and Genomics|August 30, 2014
The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemiaPaulo C J L Santos, Aline C Morgan, Cinthia E Jannes, et al.
Frontiers in Pharmacology|June 8, 2018
Association Between <i>ABCB1</i> Polymorphism and Stable Warfarin Dose Requirements in Brazilian PatientsLetícia C Tavares, Leiliane R Marcatto, Renata A G Soares, et al.
Lipids in Health and Disease|June 30, 2012
MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian populationPaulo C J L Santos, Theo G M Oliveira, Pedro A Lemos, et al.
European Journal of Haematology|February 17, 2015
Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 studyRodolfo Cançado, Murilo R Melo, Roberto de Moraes Bastos, et al.
Frontiers in Genetics|March 17, 2015
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapyJuliana Rocha Santos, Paulo R X Tomaz, Jaqueline S Issa, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|March 13, 2012
Molecular diagnostic and pathogenesis of hereditary hemochromatosisPaulo C J L Santos, Jose E Krieger, Alexandre C Pereira
Pharmacogenomics|April 28, 2018
Genotype-guided warfarin therapy: current statusLetícia C Tavares, Leiliane R Marcatto, Paulo C J L Santos
World Journal of Clinical Cases|November 1, 2017
Juvenile hemochromatosis: <i>HAMP</i> mutation and severe iron overload treated with phlebotomies and deferasiroxManuel A Lescano, Letícia C Tavares, Paulo C J L Santos
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 7, 2012
Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life settingJaqueline S Issa, Tania Ogawa Abe, Simone Moura, et al.
Anais Da Academia Brasileira De Ciencias|March 12, 2015
General aspects of muscle glucose uptakeRafael O Alvim, Marcel R Cheuhen, Silmara R Machado, et al.
Pharmacogenetics and Genomics|August 30, 2014
The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemiaPaulo C J L Santos, Aline C Morgan, Cinthia E Jannes, et al.
Frontiers in Pharmacology|June 8, 2018
Association Between <i>ABCB1</i> Polymorphism and Stable Warfarin Dose Requirements in Brazilian PatientsLetícia C Tavares, Leiliane R Marcatto, Renata A G Soares, et al.
Lipids in Health and Disease|June 30, 2012
MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian populationPaulo C J L Santos, Theo G M Oliveira, Pedro A Lemos, et al.
European Journal of Haematology|February 17, 2015
Deferasirox in patients with iron overload secondary to hereditary hemochromatosis: results of a 1-yr Phase 2 studyRodolfo Cançado, Murilo R Melo, Roberto de Moraes Bastos, et al.
Frontiers in Genetics|March 17, 2015
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapyJuliana Rocha Santos, Paulo R X Tomaz, Jaqueline S Issa, et al.
Pageof 2